Alpha DNA Investment Management’s Trane Technologies TT Stock Holding History

Alpha DNA Investment Management’s Portfolio TT Stock Details TT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,122	Closed	-$1.89M	–	169
2024 Q4	$1.89M	Buy	5,122 +2,107	+70%	+$836K	0.72%	27
2024 Q3	$1.17M	Buy	3,015 +787	+35%	+$273K	0.44%	41
2024 Q2	$733K	Buy	+2,228	New	+$709K	0.28%	78
2023 Q2	–	Sell	-8,106	Closed	-$1.49M	–	213
2023 Q1	$1.49M	Buy	+8,106	New	+$1.47M	0.44%	35
2022 Q4	–	Sell	-6,849	Closed	-$991K	–	205
2022 Q3	$991K	Buy	+6,849	New	+$1.02M	0.82%	34
2021 Q3	–	Sell	-9,904	Closed	-$1.82M	–	144
2021 Q2	$1.82M	Buy	9,904 +9,865	+25,295%	+$1.76M	1.24%	9
2021 Q1	$5K	Sell	39 -6,699	-99%	-$1.04M	0.01%	383
2020 Q4	$978K	Buy	+6,738	New	+$930K	1.04%	23

Other funds holding TT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha DNA Investment Management's TT Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Trane Technologies (TT) in Q1 2025, closing a stake of 5,122 shares — an estimated $1.89M sold.

Alpha DNA Investment Management first reported a position in TT in Q4 2020 and held it in 8 quarters. The position peaked at $1.89M in Q4 2024. 1,535 funds tracked by Wall St. Rank hold TT as of Q1 2025.

Alpha DNA Investment Management reported no remaining Trane Technologies position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 5,122 Trane Technologies shares in Q1 2025, an estimated $1.89M.
Alpha DNA Investment Management first reported a position in Trane Technologies in Q4 2020 and held it in 8 quarters.
Alpha DNA Investment Management's Trane Technologies position peaked at $1.89M in Q4 2024.
1,535 funds tracked by Wall St. Rank held Trane Technologies as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.